Skip to main content

and
  1. Article

    Open Access

    Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction

    Cell-free DNA (cfDNA) has shown promise in detecting various cancers, but the diagnostic performance of cfDNA end motifs for multiple cancer types requires verification. This study aimed to assess the utility ...

    Juqing Xu, Haiming Chen, Weifei Fan in Journal of Cancer Research and Clinical On… (2024)

  2. Article

    Open Access

    Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma

    Besides featured glucose consumption, recent studies reveal that cancer cells might prefer “addicting” specific energy substrates from the tumor microenvironment (TME); however, the underlying mechanisms remai...

    Tongyan Liu, Chencheng Han, Panqi Fang, Zhifei Ma in Journal of Hematology & Oncology (2022)

  3. Article

    Open Access

    Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

    Circulating tumor DNA (ctDNA) has been proven as a marker for detecting minimal residual diseases following systemic therapies in mid-to-late-stage non-small-cell lung cancers (NSCLCs) by multiple studies. How...

    Siwei Wang, Ming Li, **gyuan Zhang, Peng **ng, Min Wu in Journal of Hematology & Oncology (2022)